Evogene (EVGN) Tops Q4 EPS by 66c

Evogene (NASDAQ: EVGN) reported Q4 EPS of $0.06, $0.66 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $5.4 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Jack in the Box completes $500M securitized debt refinancing